Institute faculty have training and expertise in biostatistics, epidemiology, economics, decision science, outcomes analysis, health care policy and regulatory law. Research activities emphasize the evaluation of non-drug technologies, including devices, diagnostics, and procedures. A unique focus is on the evaluation of technologies during the early stages of development, from discovery to preliminary clinical testing, when extensive data regarding clinical effectiveness may not yet be available. In these instances, computer models are utilized in order to simulate expected outcomes (using the methods of decision analysis), and thereby predict costs, effectiveness, and overall impact on the healthcare system.
The specific goals of the ITA are to:
Learn more by visiting the.
Starting breast cancer screening as early as age 25 may help women who carry a genetic mutation linked to a higher risk of cancer live longer, according to a U.S. study.